This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 11, Issue 18 pp 7830—7846
Downregulation of LncRNA-XIST inhibited development of non-small cell lung cancer by activating miR-335/SOD2/ROS signal pathway mediated pyroptotic cell death
Figure 1. The correlation between LncRNA-XIST expression levels and NSCLC development. (A) Real-Time qPCR was used to screen NSCLC associated LncRNAs. (B) Real-Time qPCR was used to detect LncRNA-XIST levels in 30 paired clinical tissues collected from NSCLC patients. (C, D) LncRNA-XIST levels were compared according to lymphatic metastasis (C) and TNM stage. (E) Pan-cancer analysis was conducted to investigate the correlation of LncRNA-XIST levels and prognosis of patients with lung adenocarcinoma. (F) Kaplan-Meier analysis was used to analyse the percent survival of NSCLC patients in our experiments. (J) Real-Time qPCR was used to detect LncRNA-XIST levels in HBE, A549, H1299, SK-MES-1 and Calu-3 cell lines. (“NS” represented no statistical significance, “*” represented p < 0.05, “**” represented p < 0.01).